Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-06 Sale | 2023-03-08 4:25 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 831 | $15.26 | $12,684 | 63,429 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 7:04 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,368 | $15.96 | $37,796 | 43,260 (Direct) | View |
| 2022-03-04 Sale | 2022-03-07 8:49 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 1,023 | $16.85 | $17,234 | 79,311 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:15 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 935 | $17.75 | $16,599 | 31,734 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 4:47 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 933 | $34.2 | $31,908 | 22,167 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-02 Option Award | 2023-03-06 6:57 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 76,800 | $0 | 120,060 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:49 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 48,600 | $0 | 79,311 (Direct) | View |
| 2021-03-03 Option Award | 2021-03-05 3:53 pm | N/A 2031-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 38,300 | $0 | 60,467 (Direct) | View |
| 2020-05-31 Ownership | 2021-02-16 6:32 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 1,004 | $14.45 | 23,100 (Direct) | View |
| 2020-11-30 Ownership | 2021-02-16 6:32 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 233 | $23.05 | 23,100 (Direct) | View |
| 2020-10-26 Exercise | 2020-10-27 2:03 pm | N/A 2029-10-28 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,668 | $0 | 168,943 (Direct) | View |
| 2020-10-26 Exercise | 2020-10-27 2:03 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,668 | $6.52 | 168,943 (Direct) | View |
| 2020-10-22 Exercise | 2020-10-23 1:27 pm | N/A 2029-10-28 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,695 | $0 | 168,943 (Direct) | View |
| 2020-10-22 Exercise | 2020-10-23 1:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,695 | $6.52 | 168,943 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 2:06 pm | N/A 2029-10-28 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 7,500 | $0 | 168,943 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 2:06 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 7,500 | $6.52 | 168,943 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:05 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 36,000 | $0 | 36,000 (Direct) | View |
Ownership | 2020-01-30 7:58 pm | N/A 2029-10-28 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 0 | $0 | 159,943 (Direct) | View |